ranking lower than Streptococcus pneumoniae. 10, 11 The rates of upper respiratory infections differ across studies and may range by up to 50%. 1 Although M pneumoniae can lead to infections in any epidemiologic setting, it shows a particularly significant burden in closed community settings, where outbreaks arise. Numerous outbreaks were recorded since the 1960s in different settings, for example, hospitals, 12, 13 institutions, 14, 15 military bases, 16, 17 and religious communities. 18, 19 In many patients, the symptomatic infections are mild, steady, and continue for weeks. However, severe cases requiring hospitalization and even death may happen, particularly among aging or immunocompromised people. Up to 25% of M pneumoniae patients presented extrapulmonary manifestations including the central nervous system, mucous membrane, and cardiovascular system. 20 Some complications, for example, neurological manifestations, cause grave outcomes. Antibiotic treatment significantly moderates the symptoms and signs even before the thorough elimination of the bacteria. Early and rapid diagnosis of M pneumoniae infections has important clinical significance for the selection of correct antibiotics.
The clinical manifestation of patients with M pneumoniae infections shows no significant differences with other respiratory pathogen infections, such as Chlamydia pneumoniae; therefore, it is impossible to identify M pneumoniae infections only according to the clinical signs and symptoms, and laboratory tests for identifying M pneumoniae are especially important. However, there is lack of a definite standard test for diagnosis of M pneumoniae. 21 Mycoplasma pneumoniae culture is time-consuming because it grows slowly (about 2 to 5 weeks for visible colonies appear). 22 Serological assays are the most widely used technique in the laboratory diagnosis of M pneumoniae infections; nevertheless, the sensitivity of serology depends on the time phase when the first serum sample is collected after the M pneumoniae infections and the availability of the paired serum samples collected with a 2-3-week interval, as well as the sensitivity during the acute infectious stage. 23 In addition, serological measurements of host immune responses did not directly measure organism load. Some infected patients have never found a detectable antibody response. 24 Conversely, M pneumoniae IgM positive is also seen in healthy children. 25 Thus, a nucleic acid amplification technique of was used, 26 which includes polymerase chain reaction (PCR) to amplify the specific DNA fragment and the nuclear acid sequence-based amplification (NASBA) using RNA templates to diagnose M pneumoniae infections. Compared with serology, PCR is rapid and sensitive with high specificity and is thus good for the early clinical diagnosis of M pneumoniae infection. 27 Some experts recommend PCR as the gold standard for M pneumoniae diagnosis.
Compared with PCR, no DNA digestion enzyme pretreatment was necessary for NASBA to amplify RNAs. Additionally, NASBA does not need an expensive nucleic acid amplification reaction device when performing constant temperature amplification. NASBA can be completed with a regular constant temperature water bath because the entire process is carried out at 42°C instead of the thermal cycler and is thus very convenient. 28 Meanwhile, only a few enzymatic cyclings are needed for NASBA to achieve the required target amount. For instance, to reach 10 6 amplification, PCR requires 20 cycles, while only 4-5 cycles are needed for NASBA. Moreover, the mismatching rate is low and the cycle is shorter for NASBA than RT-PCR. 29 Therefore, it is worth exploring the diagnostic value of NASBA for M pneumoniae infections. NASBA has been shown to have a good diagnostic value for M pneumoniae infections compared with PCR as the gold standard; however, the evidence is not sufficient due to the relatively independent studies and small sample size. The aim of the current study was to perform a systematic review and metaanalysis to evaluate the overall accuracy of NASBA to diagnose of M pneumoniae infections, as well as to provide powerful evidence for the possibility of using NASBA to diagnose M pneumoniae infections. 
| MATERIAL AND ME THODS

| Search strategy and selection criteria
| Inclusion criteria
Literature screening was conducted according to the inclusion criteria for the diagnostic test study from the Collaboration Screening and Diagnostic Test Method Group in the Cochrane Library. Quality assessment of included studies: The methodological quality of the included studies was evaluated using the QUADAS-2 tool recommended by the Cochrane Collaboration, and the RevMan 5.2 statistical software was used to display the quality of the study.
| Statistical methods
The pooled analysis was performed using Meta-DiSc 1.4 software.
The ROC topographical plan was drawn, and the Spearman correlation coefficient between the logarithm of the sensitivity and logarithm of the (1-specificity) was calculated to determine whether there was a threshold effect. There was threshold effect if P < 0.05.
The random-effects model was used to calculate the pooled param- 
| RE SULTS
| Literature identification and selection
The detailed process of the literature identification and selection is shown in Figure 1 . A total of 26 publications were retrieved according to the search strategy described in the methods section (12 from PubMed, 0 from Cochrane Library, 5 from Google Scholar, 5 from CNKI, 2 from Wanfang, and 6 from Baidu Scholar), while nine duplicate studies, three reviews, four unrelated articles, and three articles without full text were excluded after reviewing the titles and abstracts. One article with incomplete original data and one article with data published repeatedly were further excluded after reading the full text. Finally, six articles [30] [31] [32] [33] [34] [35] meeting the inclusion criteria were included in this meta-analysis.
| Characteristics and quality evaluation of the included studies
Ten groups of relatively independent data were included in the six included studies. The characteristics of the six included studies are shown in Table 1 . The methodological quality of the articles was evaluated using the QUADAS-2 tool. As shown in Figure 2 , our results showed that the quality of the six included studies was high and that therefore the included studies were representative. Four studies were from Belgium, one study was from the Netherlands and one from France. Four studies were prospective and two studies did not report the study design method.
F I G U R E 1 Flow diagram of study identification and inclusion
| Meta-analysis and overall diagnostic accuracy
Threshold effect analysis: The scatter plot of the ROC topographical plan made from Meta-Disc 1.4 software showed an atypical "shoulder-arm shape." The Spearman correlation coefficient is r = 0.012 and P = 0.973, suggesting that Sen was negatively correlated with 1-Spe, with no existing threshold effect.
The pooled results: a meta-analysis was conducted for the pooled data extracted from the included studies using a random effects model. The results showed that SEN was 0.77 (95% CI: 0.71 to 0.82) ( Figure S1 ); SPE was 0.98 (95% CI: 0.98 to 0.99) ( Figure S2 ); + LR was 50.38 (95% CI: 21.85 to 116.17) ( Figure S3 ); −LR was 0.22 (95% CI: 0.13 to 0.39) ( Figure S4) ; DOR was 292.72 (95% CI: 95.02 to 901.75) ( Figure S5) ; the area under the SROC curve (AUC) was 0.9875 and the Q* index was 0.9525 ( Figure 3 ). The results of the pooled results suggest that NASBA shows a higher accuracy in the diagnosis of M pneumoniae infections, in which the potential to identify individuals without infections is higher than that to identify individuals with infections.
Our results showed that heterogeneity existed in the sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio (the I 2 was 82.3%, 80.6%, 62.8%, 79.5%, 62.4%, respectively). A meta-regression analysis performed using the Meta-DiSc 1.4 software for researchers, countries, nucleic acid extraction techniques, and detection methods showed that all P > 0.05, indicating that these factors are not able to explain the heterogeneity between the included studies.
Other unknown factors led to the production of heterogeneity across the studies.
Publication bias assessment: Stale 12.0 software was used to make the Deeks' funnel plot to identify publication bias for the included studies, and the linear regression model was used to test the symmetry of the funnel plot. Our result showed that P = 0.016, indicating the existence of publication bias (Figure 4 ). However, M pneumoniae is difficult to culture with a low positive isolation rate and long duration; thus, M pneumoniae culture is not suitable for rapid clinical diagnosis. 36 Therefore, the diagnosis of M pneumoniae infections essentially relied on serology. 37 Unfortunately, the serological test has low sensitivity, poor specificity, and cross-reactivity with other respiratory mycoplasmas or viruses. [38] [39] [40] [39] [40] [41] [42] Nuclear acid sequence-based amplification has been reported to show a high sensitivity and specificity in the detection of M pneumoniae infection, as well as an even higher value than PCR in the detection of certain microbial infections, such as invasive fungal infections. 43 In addition, NASBA also has the advantage of no thermal cycling instruments required with high amplification efficiency, 28 which warrants further development and utilization. However, different diagnostic studies in this field have generated inconsistent diagnostic accuracy due to the small sample size, and the exact diagnostic accuracy of NASBA for M pneumoniae is difficult to establish.
TA B L E 1 Characteristics of the included studies
There are currently no systematic reviews or meta-analyses assessing NASBA for the detection of M pneumoniae; therefore, this systematic review and meta-analysis were conducted with the intention to provide more powerful evidence for the feasibility of NASBA in the diagnosis of M pneumoniae infections.
The results of ourmeta-analysis showed that the pooled specificity was 0.98 (95% CI: 0.98 to 0.99), suggesting that NASBA had a The diagnostic value of NASBA will also increase as it is developed.
(iv) The number of included studies is relatively small. (v) There are deficiencies in using PCR positive as a gold standard. For example, high sensitivity of PCR may lead to false positives. 24, 45 In conclusion, the present systematic review and meta-analysis suggest an important diagnostic value of NASBA for M pneumoniae infections based on the available evidence. The rapid clinical diagnosis of M pneumoniae infections using NASBA is feasible, and it can be used as an effective supplement for laboratory diagnosis of M pneumoniae. However, the above conclusion still needs to be further verified with a larger sample size and more involved areas.
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